Catabasis Pharma Raises Nearly $40 Million

Catabasis Pharmaceuticals, a Cambridge, Mass.-based drug startup focused on inflammatory and metabolic diseases, has raised $39.6 million in Series A funding. Backers include SV Life Sciences, Clarus Ventures, MedImmune Ventures and Advanced Technology Ventures.

North AmericaUSBriefs